Viewing Study NCT00832403


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2025-12-27 @ 12:12 PM
Study NCT ID: NCT00832403
Status: SUSPENDED
Last Update Posted: 2009-01-30
First Post: 2009-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gore Tex Implants in the Treatment of Atrophic Rhinitis
Sponsor: Hospital Felicio Rocho
Organization:

Study Overview

Official Title: Gore Tex Implants in the Treatment of Atrophic Rhinitis
Status: SUSPENDED
Status Verified Date: 2009-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: lack of new patients
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RA
Brief Summary: This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.
Detailed Description: Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: